Australian Government - Department of Health

Medical Services Advisory Committee (MSAC)

1230 - Testing for HER2 positivity in patients diagnosed with breast cancer to determine eligibility for treatment with trastuzumab

Assessment No

1230
Application NameTesting for HER2 positivity in patients diagnosed with breast cancer to determine eligibility for treatment with trastuzumab
AssessmentSubmission Based
Description Of Medical Service-
Medical Service Category-
Medical Service Type-
Medical Service Sub Type-
Description Of Medical Condition-
Medical ConditionCancer
Medical Condition Sub TypeBreast
Submission of Collated EvidenceSubmission Based Application
MSAC Appraisal2-3 August
PDF version Public Summary Document
Word version Public Summary Document
MSAC advicePDF version Minutes (PDF 11 KB)
Word version Minutes (Word 35 KB)
Noting by Minister -
Implementation-

Page currency, Latest update: 07 November, 2014


File Attachment Icon
MSAC-56th-ShortMinutes-1230-HER2-trastuzumab-Redacted.pdf
File Attachment Icon
PSD-1230-HER2ISHfortrastuzumab-56thMeeting.docx
File Attachment Icon
PSD-1230-HER2ISH-for-trastuzumab-56th-Meeting.pdf
File Attachment Icon
MSAC-56th-ShortMinutes-1230-HER2-trastuzumab-Redacted-Accessible.docx